NCT04047810View on ClinicalTrials.gov

Mesenchymal Stem Cells in the Treatment of Subjects with Advance Chronic Obstructive Pulmonary Disease (COPD)

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

November 21, 2023

Study Completion Date

August 31, 2025

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
BIOLOGICAL

Mesenchymal Stem Cells

0.5- 2 million cells/kg, intravenously once

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04047810 - Mesenchymal Stem Cells in the Treatment of Subjects with Advance Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter